Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Kasilingam v. Tilray, Inc. et al
Case Number:
1:20-cv-03459
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker & Hostetler
- Bernstein Liebhard
- Bleichmar Fonti
- Glancy Prongay
- Kahn Swick
- Levi & Korsinsky
- Offit Kurman
- Pomerantz LLP
- Robbins Geller
Companies
Sectors & Industries:
-
August 22, 2023
Tilray Gets Securities Suit Tossed On Reconsideration
A New York federal judge has thrown out a securities suit alleging cannabis company Tilray Inc. and its CEO misled investors about the value of a partnership, admitting the court had made an error in law and was "too lenient" on the pleadings when it partially denied the company's prior bid to dismiss.
-
October 14, 2022
Tilray Says Wrong Standard Used In Securities Fraud Order
Cannabis company Tilray Inc. is asking a New York federal judge to reconsider his order finding that investors had plausibly alleged the company's officers defrauded them by overstating the advantages of a partnership, saying the judge committed "clear error" by applying a lower pleading standard than the law requires.
-
September 27, 2021
Tilray Gets Securities Fraud Claims Tossed For Now
A New York federal judge on Monday dismissed without prejudice a securities fraud class action against Canadian marijuana giant Tilray, saying the plaintiffs had failed to adequately plead scienter in their amended complaint.
-
January 26, 2021
Tilray Shareholders Seek To Keep Original Claims Alive
Stockholders of Canadian pot giant Tilray have urged a Manhattan federal court to reject the company's motion to dismiss their securities fraud suit, saying the company falsely declared that the court can assume the facts stated in certain documents it provided are true.
-
December 07, 2020
Pot Biz Tilray Wants Investor Suit Over $180M Writedown Axed
Canadian pot giant Tilray has asked a Manhattan federal court to toss a securities fraud suit alleging it blindsided investors with $180 million in accounting charges, arguing the asset write-downs stemmed largely from unforeseeable regulatory setbacks.
-
August 10, 2020
Rosen Law Firm To Lead Tilray Stock-Drop Suit
The Rosen Law Firm will lead a proposed class of investors in a stock-drop suit against the Canadian medical cannabis company Tilray Inc., a New York federal judge has ordered, saying the firm's client satisfies the lead plaintiff requirements and has the largest financial interest in the case.